Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one - Jorge Gonçalves; Catarina D. Santos; Paula Fresco; Fernando Fernandez-Llimos (Revista Portuguesa de Cardiologia, 2024)